Renaissance Technologies’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$288K Buy
+292,400
New +$288K ﹤0.01% 3056
2025
Q1
Sell
-578,800
Closed -$1.27M 3560
2024
Q4
$1.27M Sell
578,800
-335,300
-37% -$738K ﹤0.01% 2345
2024
Q3
$1.51M Sell
914,100
-507,800
-36% -$838K ﹤0.01% 2198
2024
Q2
$3.16M Sell
1,421,900
-694,600
-33% -$1.54M 0.01% 1586
2024
Q1
$5.67M Buy
2,116,500
+696,400
+49% +$1.87M 0.01% 1338
2023
Q4
$4.25M Buy
1,420,100
+1,213,944
+589% +$3.63M 0.01% 1454
2023
Q3
$202K Buy
206,156
+91,856
+80% +$90K ﹤0.01% 3090
2023
Q2
$159K Buy
+114,300
New +$159K ﹤0.01% 3341
2022
Q4
Sell
-286,700
Closed -$1.92M 4183
2022
Q3
$1.92M Sell
286,700
-98,600
-26% -$661K ﹤0.01% 2042
2022
Q2
$2.45M Sell
385,300
-36,900
-9% -$235K ﹤0.01% 2039
2022
Q1
$1.96M Buy
+422,200
New +$1.96M ﹤0.01% 2245
2019
Q4
Sell
-141,900
Closed -$5.2M 3558
2019
Q3
$5.2M Sell
141,900
-95,600
-40% -$3.5M ﹤0.01% 1770
2019
Q2
$11M Buy
237,500
+41,905
+21% +$1.95M 0.01% 1334
2019
Q1
$7.85M Buy
195,595
+177,695
+993% +$7.13M 0.01% 1512
2018
Q4
$823K Buy
+17,900
New +$823K ﹤0.01% 2668
2017
Q4
Sell
-14,500
Closed -$727K 3378
2017
Q3
$727K Buy
+14,500
New +$727K ﹤0.01% 2685
2016
Q4
Sell
-318,800
Closed -$4.42M 3297
2016
Q3
$4.42M Buy
+318,800
New +$4.42M 0.01% 1683
2016
Q2
Sell
-107,600
Closed -$1.82M 3374
2016
Q1
$1.82M Sell
107,600
-253,600
-70% -$4.29M ﹤0.01% 2279
2015
Q4
$8.04M Buy
+361,200
New +$8.04M 0.02% 1140